Le Lézard
Classified in: Health, Business, Covid-19 virus
Subjects: ERN, MAT

4Front Announces Second Quarter 2020 Results and Business Update


PHOENIX, Ariz., Aug. 31, 2020 /CNW/ - 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) ("4Front" or the "Company") today announced its financial results for the Second Quarter of 2020.

Second Quarter 2020 Financial Results Highlights

Business Update

Robust consumer demand continues across all operating markets.  Recreational sales in Georgetown, MA progressing steadily since August 12th launch, sales at Mission South Chicago are on pace to climb back to pre-shut down levels since the re-opening on July 31stWashington experienced record sales in July with that momentum carrying into August.

Company reaches cash flow goals ahead of schedule.  Achieves positive operating cash flow in the month of August and expects to generate positive adjusted EBITDA for Q3 2020.  Poised to show significant operating leverage in 2021.

All construction and expansion projects remain on budget and on schedule.  Fully funded expansion plans at Elk Grove, IL and Georgetown, MA cultivation/production facilities are expected to be completed in Q4.  Second Illinois retail location in Calumet City also remains on schedule for a Q4 opening.

Completion of non-core asset divestitures nearing completion.  Divestitures of non-core retail assets in Arizona, Arkansas and Pennsylvania are complete.  Close of Maryland divestitures expected to be completed in early September.

Washington Financing/Sale Leaseback Update.  As of June 30, 2020, 4Front's balance sheet had cash and equivalents of $11.4m with total debt of $78.3m (excluding in-the-money convertible debt of $5.8m). The Company owns and controls highly attractive real estate in Washington state consisting of 176,000 square feet of state-of-the-art industrial space built for cultivation, production and distribution. The Company is in progressive discussions with multiple partners on this transaction.

Management Commentary

Leo Gontmakher, CEO of 4Front, said, "Entering 2020, we have been laser-focused on leaning out and replicating our low-cost cultivation and production model in targeted states. We enter the second half of 2020 with a focused business model, streamlined cost structure and fortified balance sheet that has set the stage for us to accelerate growth across our core markets of Washington, Illinois, Massachusetts, Michigan and California.

Mr. Gontmakher added: "Our strong business momentum leaving the second quarter will be aided by significant tailwinds as we enter the second half of this year.  We welcomed the first adult-use sales in Massachusetts at our Georgetown facility on August 12th and anticipate final approvals for adult use sales at our Worcester facility imminently.  Our cultivation/processing facility expansions in Massachusetts and Illinois as well as our second Illinois retail location are on-track for end of year completion.  We continue to execute on our plans to flip to cash flow positive during the third quarter and have set the stage to exit this year in a position to drive meaningful operating leverage in our business. We are proving that our success in Washington can be replicated in every state in which we operate and are extremely confident in how the company is positioned as we enter this new season." 

(Please see Note Regarding Non-IFRS Measures, Reconciliation, and Discussion below.) (*Please see the Financial Statement section below, and the Company's Second Quarter 2020 Unaudited Condensed Consolidated Financial Statements and Management Discussion and Analysis ("MD&A"), available under the Company's SEDAR profile, for more information.)

Additional Details

As of the date of the MD&A, there were the equivalent of 506,379,437 Class A Subordinate Voting Shares outstanding when calculated as if all share classes were converted to Subordinate Voting Shares. For further details regarding 4Front's share structure, please see its profile at www.thecse.com.

Conference Call

The Company will also host a conference call and webcast on Monday, August 31, 2020 at 5:00 p.m. EDT to review its operational and financial results and provide an update on current business trends.

To join the call, dial 1-877-407-0792 toll free from the United States or Canada or 1-201-689-8263 if dialing from outside those countries. The webcast, which will include a slide deck, can be accessed at this link.

The call will be available for replay until Monday, September 7, 2020. To access the telephone replay, dial 844-512-2921 toll free from the United States and Canada, or 1-412-317-6671 if dialing from outside those countries, and use this replay pin number: 13708994.

Financial Statements

The condensed consolidated interim financial statements for the three and six months ended June 30, 2020 and 2019, have been prepared in accordance with IAS 34 ? Interim Financial Reporting. These statements have not been reviewed by an auditor.

4FRONT VENTURES CORP.




Formerly 4Front Holdings, LLC




Condensed Consolidated Interim Statements of Financial Position



As of June 30, 2020 and December 31, 2019 (unaudited)




Amounts expressed in thousands United States dollars unless otherwise stated








 June 30, 


 December 31, 


2020


2019

ASSETS




Current assets:




Cash 

$

11,434


$

5,789

Accounts receivable

560


677

Other receivables

261


325

     Lease receivables

10,787


9,556

Inventory

12,447


9,138

Biological assets

2,190


2,187

Notes receivable

1,362


1,871

Prepaid expenses

1,845


2,198

Assets held for sale

7,336


-

Total current assets

48,222


31,741





Restricted cash

-


2,352

Property and equipment, net

40,977


41,822

Notes receivable 

520


1,049

Lease receivables

22,876


23,944

Intangible assets

39,888


41,442

Goodwill

28,854


33,988

Right-of-use assets

30,991


20,476

Investments

759


759

Deposits

3,493


6,346

TOTAL ASSETS

$

216,580


$

203,919





LIABILITIES AND EQUITY








LIABILITIES




Current liabilities:




Accounts payable and accrued expenses

$

6,591


$

8,138

Taxes payable

4,198


1,609

Lease liability

971


972

Contingent consideraton payable

2,100


750

Notes payable and accrued interest

6,750


7,382

Liabilities held for sale

1,752


-

Total current liabilities

22,362


18,851





Convertible notes

45,645


35,607

Notes payable and accrued interest

43,878


44,289

Long term notes payable

1,978


1,903

Long term accounts payable

1,600


1,600

Contingent consideration payable

2,994


4,714

Deferred tax liability

2,014


-

Lease liability

31,758


20,976

TOTAL LIABILITIES

152,229


127,940





Equity (Deficiency)




Equity attributable to 4Front Ventures Corp.

238,995


252,656

Reserves

34,111


25,618

Deficit

(208,464)


(202,090)

Non-controlling interest

(291)


(205)

TOTAL EQUITY (DEFICIENCY)

64,351


75,979

TOTAL LIABILITIES AND EQUITY (DEFICIENCY) 

$

216,580


$

203,919

 

4FRONT VENTURES CORP.








Formerly 4Front Holdings, LLC







Condensed Consolidated Interim Statements of Operations and Comprehensive Loss



For The Three and Six Months Ended June 30, 2020 and 2019 (unaudited)



Amounts expressed in thousands United States dollars unless otherwise stated











Three Months Ended


Six Months Ended


June 30, 2020


June 30, 2019


June 30, 2020


June 30, 2019









REVENUE

$

12,701


$

2,518


$

25,353


$

4,605









Cost of goods sold, sale of grown and manufactured products

(5,034)


(1,494)


(7,849)


(2,349)

Cost of goods sold, sale of purchased products

(3,012)


(529)


(4,846)


(676)

Gross profit before fair value adjustments

4,655


495


12,658


1,580









Realized fair value included in inventory sold

(436)


(321)


(573)


(112)

Unrealized fair value gain on biological assets

1,480


169


1,853


495

Gross profit

5,699


343


13,938


1,963









OPERATING EXPENSES
















Selling and marketing expenses

5,633


1,359


11,817


3,206

General and administrative expenses

2,873


5,620


8,096


9,277

Depreciation and amortization

1,109


386


2,160


706

Equity based compensation

1,048


459


2,275


709

Total operating expenses

10,663


7,824


24,348


13,898









Loss from Operations

(4,964)


(7,481)


(10,410)


(11,935)









Other Income (Expense)








Interest income

8


-


64


-

Interest expense

(3,685)


(936)


(6,953)


(1,123)

Accretion

158


-


331


-

Gain on sale of subsidiary

9,559


-


11,211


-

Gain on restructuring of notes receivable

281


-


281


-

Other income

2,456


2,500


2,456


2,500

Foreign exchange loss

(55)


-


(18)


-

Total Other Income (Expense)

8,722


1,564


7,372


1,377









Net Loss from Continuing Operations Before Income Taxes

3,758


(5,917)


(3,038)


(10,558)

Income Tax Expense

(2,179)


(239)


(2,923)


(452)

Net Loss from Continuing Operations, Net of Taxes

1,579


(6,156)


(5,961)


(11,010)









Net (Loss) Income from Discontinued Operations, Net of Taxes

127


(351)


(499)


(950)









Net Loss

1,706


(6,507)


(6,460)


(11,960)

Net Loss Attributable To Non-Controlling Interest

(68)


(24)


(86)


(110)









Net Loss Attributable to Shareholders

$

1,774


$

(6,483)


$

(6,374)


$

(11,850)









Basic and Diluted Loss Per Share

$

-


$

(0.02)


$

(0.01)


$

(0.03)

Weighted Average Number of Shares Outstanding, Basic and Diluted

506,379,437


340,370,271


506,379,437


340,370,271

Note Regarding Non-IFRS Measures, Reconciliation, and Discussion

In this press release, 4Front refers to certain non-IFRS financial measures such as Systemwide Pro Forma Revenue and Adjusted EBITDA. These measures do not have any standardized meaning prescribed by IFRS and may not be comparable to similar measures presented by other issuers. 4Front defines Systemwide Pro Forma Revenue as total revenue plus revenue from entities with which the Company has a management contract, or effectively similar relationship (net of any management fee or effectively similar revenue) but does not consolidate the financial results of per IFRS 10 ? Consolidated Financial Statements. 4Front considers this measure to be an appropriate indicator of the growth and scope of the business.

Adjusted EBITDA is defined by the Company as earnings before interest, taxes, depreciation and amortization less share-based compensation expense and one-time charges related to acquisition and financing related costs, excluding fair value adjustments for biological assets. 4Front considers these measures to be an important indicator of the financial strength and performance of our business. The following tables provide a reconciliation of each of the non-IFRS measures to its closest IFRS measure.

 About 4Front Ventures Corp.
4Front (CSE: FFNT) (OTCQX: FFNTF) is a national multi-state cannabis operator and retailer, with a market advantage in mass-produced, low-cost quality branded cannabis products. 4Front manufactures and distributes a portfolio of over 25 cannabis brands including Marmas, Crystal Clear, Funky Monkey, Pebbles, and the Pure Ratios wellness collection, distributed through retail outlets and their chain of strategically positioned Mission branded dispensaries.

Headquartered in Phoenix, Arizona, 4Front has operations in Illinois, Massachusetts, California, Michigan and Washington state. From plant genetics to the cannabis retail experience, 4Front's team applies expertise across the entire cannabis value chain. For more information, visit 4Front's website 

This news release was prepared by management of 4Front Ventures, which takes full responsibility for its contents. The Canadian Securities Exchange ("CSE") has not reviewed and does not accept responsibility for the adequacy of this news release. Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Forward Looking Statements

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in 4Front Ventures' periodic filings with securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward-looking statements.

Forward-looking statements may include, without limitation, statements related to future developments and the business and operations of 4Front Ventures, developments with respect to legislative developments in the United States, expectations regarding the COVID-19 pandemic, future revenue or Adjusted EBITDA expectations, statements regarding when or if any contemplated or in-progress transactions will close or if/when required regulatory approvals are attained, and other statements regarding future developments of the business. The closing of the transactions described in this news release, including the divesture of Pennsylvania and Maryland assets and the sale of convertible debt, is subject to customary conditions and there can be no guarantee that such transactions will close.

Although 4Front Ventures has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in target companies or projects which have limited or no operating history and are engaged in activities currently considered illegal under U.S. federal laws; change in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.

There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. 4Front Ventures disclaims any intention or obligation to update or revise such information, except as required by applicable law, and 4Front Ventures does not assume any liability for disclosure relating to any other company mentioned herein.

SOURCE 4Front


These press releases may also interest you

at 10:01
The Predictive Maintenance Market is estimated to grow from USD 10.6...

at 08:40
The "Global Cell Counting Market: Analysis By Product, By Application, By End-User, By Region Size, Trends and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. The global cell counting market was valued at US$9.98...

at 06:15
The "Global Immune Health Supplements Market - Outlook & Forecast 2023-2028" report has been added to  ResearchAndMarkets.com's offering. The global immune health supplements market was valued at $20.80 billion in 2022 and is expected to reach...

at 05:45
The Gross Law Firm issues the following notice to shareholders of Amplitude, Inc. . Shareholders who purchased shares of AMPL during...

at 05:45
The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ....

at 05:30
The "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and by Country. With Market Analysis and Executive Guides. 2024 to 2028" report has been added to...



News published on and distributed by: